{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T02:19:10Z","timestamp":1783045150002,"version":"3.54.6"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005076","name":"Agricultural Research Development Agency","doi-asserted-by":"publisher","award":["CRP6705031540"],"award-info":[{"award-number":["CRP6705031540"]}],"id":[{"id":"10.13039\/501100005076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ejpb.2026.115098","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T02:55:50Z","timestamp":1778554550000},"page":"115098","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["In vivo pharmacokinetic and toxicity evaluation of Andrographis paniculata extract-loaded self-microemulsifying drug delivery system"],"prefix":"10.1016","volume":"225","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6540-280X","authenticated-orcid":false,"given":"Chaiyakarn","family":"Pornpitchanarong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saran","family":"Jaewjira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3879-0936","authenticated-orcid":false,"given":"Theerada","family":"Taesotikul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0606-3830","authenticated-orcid":false,"given":"Praneet","family":"Opanasopit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4974-4532","authenticated-orcid":false,"given":"Prasopchai","family":"Patrojanasophon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2026.115098_b0005","first-page":"66","article-title":"Andrographis paniculata: a review of pharmacological activities and clinical effects","volume":"16","author":"Akbar","year":"2011","journal-title":"Altern. Med. Rev."},{"key":"10.1016\/j.ejpb.2026.115098_b0010","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1080\/10408398.2018.1501657","article-title":"Overview of pharmacological activities of Andrographis paniculata and its major compound andrographolide","volume":"59","author":"Dai","year":"2019","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.ejpb.2026.115098_b0015","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/846740","article-title":"Experimental and Clinical Pharmacology of Andrographis paniculata and its Major Bioactive Phytoconstituent Andrographolide","volume":"2013","author":"Jayakumar","year":"2013","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.ejpb.2026.115098_b0020","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1440-1681.2011.05633.x","article-title":"Andrographolide and its analogues: versatile bioactive molecules for combating inflammation and cancer","volume":"39","author":"Lim","year":"2012","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ejpb.2026.115098_b0025","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.3390\/molecules27144479","article-title":"A Comprehensive review of andrographis paniculata (Burm. f.) nees and its constituents as potential lead compounds for COVID-19 drug discovery, in","author":"Intharuksa","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejpb.2026.115098_b0030","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1598255","article-title":"Exploring the clinical effects of Andrographis paniculata-derived compounds, its extract, or derivatives for the treatment of COVID-19: a systematic review and meta-analysis","volume":"16","author":"Prabhakornritta","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejpb.2026.115098_b0035","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s13318-010-0016-7","article-title":"Improved bioavailability of orally administered andrographolide from pH-sensitive nanoparticles","volume":"35","author":"Chellampillai","year":"2011","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.ejpb.2026.115098_b0040","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/ptr.7324","article-title":"Andrographolide: a review of its pharmacology, pharmacokinetics, toxicity and clinical trials and pharmaceutical researches","volume":"36","author":"Zeng","year":"2022","journal-title":"Phytother. Res."},{"key":"10.1016\/j.ejpb.2026.115098_b0045","doi-asserted-by":"crossref","unstructured":"J.P. Loureiro Damasceno, H. Silva da Rosa, L. Silva de Araujo, N.A. Jacometti Cardoso Furtado, Andrographis paniculata Formulations: Impact on Diterpene Lactone Oral Bioavailability, Eur J Drug Metab Pharmacokinet, 47 (2022) 19-30.","DOI":"10.1007\/s13318-021-00736-7"},{"key":"10.1016\/j.ejpb.2026.115098_b0050","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1230401","article-title":"Comparative pharmacokinetics and safety evaluation of high dosage regimens of Andrographis paniculata aqueous extract after single and multiple oral administration in healthy participants","volume":"14","author":"Songvut","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejpb.2026.115098_b0055","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1002\/jps.22693","article-title":"Poor oral bioavailability of a promising anticancer agent andrographolide is due to extensive metabolism and efflux by P-glycoprotein","volume":"100","author":"Ye","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115098_b0060","doi-asserted-by":"crossref","first-page":"69282","DOI":"10.1039\/C6RA12161F","article-title":"Strategies for formulation development of andrographolide","volume":"6","author":"Pawar","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejpb.2026.115098_b0065","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1016\/j.ddtec.2012.03.002","article-title":"Lipid-based formulations for oral delivery of lipophilic drugs","volume":"9","author":"Kuentz","year":"2012","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.ejpb.2026.115098_b0070","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ejps.2006.04.016","article-title":"Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system","volume":"29","author":"Pouton","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115098_b0075","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1517\/17425247.3.1.97","article-title":"Development of supersaturatable self-emulsifying drug delivery system formulations for improving the oral absorption of poorly soluble drugs","volume":"3","author":"Gao","year":"2006","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2026.115098_b0080","doi-asserted-by":"crossref","unstructured":"P. Uttreja, I. Karnik, A. Adel Ali Youssef, N. Narala, R.M. Elkanayati, S. Baisa, N.D. Alshammari, S. Banda, S.K. Vemula, M.A. Repka, Self-Emulsifying Drug Delivery Systems (SEDDS): Transition from Liquid to Solid\u2014A Comprehensive Review of Formulation, Characterization, Applications, and Future Trends, in: Pharmaceutics, 2025.","DOI":"10.3390\/pharmaceutics17010063"},{"key":"10.1016\/j.ejpb.2026.115098_b0085","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16020166","article-title":"Development and optimization of andrographis paniculata extract-loaded self-microemulsifying drug delivery system using experimental design model","volume":"16","author":"Pornpitchanarong","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115098_b0090","unstructured":"International Conference on Harmonisation, ICH guideline M3(R2) on non-clinical safety studies for the conduct of human clinical trials and marketing authorisation for pharmaceuticals, (2009) 1-26."},{"key":"10.1016\/j.ejpb.2026.115098_b0095","unstructured":"OECD, Test No. 407: Repeated Dose 28-day Oral Toxicity Study in Rodents, OECD Guidelines for the Testing of Chemicals, Section 4,, (2025)."},{"key":"10.1016\/j.ejpb.2026.115098_b0100","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2026.115098_b0105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11095-004-9004-4","article-title":"Predicting drug disposition via application of BCS: transport\/absorption\/ elimination interplay and development of a biopharmaceutics drug disposition classification system","volume":"22","author":"Wu","year":"2005","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2026.115098_b0110","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1023\/A:1016268311867","article-title":"Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects","volume":"12","author":"Constantinides","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2026.115098_b0115","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0928-0987(02)00055-6","article-title":"Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers","volume":"16","author":"Rege","year":"2002","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115098_b0120","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.drudis.2008.04.006","article-title":"Development of solid self-emulsifying drug delivery systems: preparation techniques and dosage forms","volume":"13","author":"Tang","year":"2008","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejpb.2026.115098_b0125","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6224107","article-title":"Acute and subacute toxicity assessment of andrographolide-2-hydroxypropyl-beta-cyclodextrin complex via oral and inhalation route of administration in sprague-dawley rats","author":"Chandrama Singh","year":"2022","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.ejpb.2026.115098_b0130","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1023\/B:PHAM.0000016235.32639.23","article-title":"Solubilizing excipients in oral and injectable formulations","volume":"21","author":"Strickley","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2026.115098_b0135","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1080\/01926230490465874","article-title":"Relationships between organ weight and body\/brain weight in the rat: what is the best analytical endpoint?","volume":"32","author":"Bailey","year":"2004","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.ejpb.2026.115098_b0140","series-title":"Assessing Ocular Toxicology in Laboratory Animals","first-page":"159","article-title":"Toxicologic Pathology of the Eye: histologic Preparation and Alterations of the Anterior Segment","author":"Schafer","year":"2013"},{"key":"10.1016\/j.ejpb.2026.115098_b0145","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0166-4328(88)90157-X","article-title":"A new one-trial test for neurobiological studies of memory in rats. 1: behavioral data","volume":"31","author":"Ennaceur","year":"1988","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejpb.2026.115098_b0150","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10339-011-0430-z","article-title":"The novel object recognition memory: neurobiology, test procedure, and its modifications","volume":"13","author":"Antunes","year":"2012","journal-title":"Cogn. Process."},{"key":"10.1016\/j.ejpb.2026.115098_b0155","first-page":"233","article-title":"A method for the routine assessment of fore and Hindlimb grip strength of rats and mice","volume":"1","author":"Meyer","year":"1979","journal-title":"Neurobehav. Toxicol. Teratol."},{"key":"10.1016\/j.ejpb.2026.115098_b0160","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.2042-7158.1968.tb09743.x","article-title":"The quantiative measurement of motor inco-ordination in naive mice using an acelerating rotarod","volume":"20","author":"Jones","year":"1968","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2026.115098_b0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189837","article-title":"Sex-specific reference intervals of hematologic and biochemical analytes in Sprague-Dawley rats using the nonparametric rank percentile method","volume":"12","author":"He","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpb.2026.115098_b0170","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1053\/j.jepm.2007.12.004","article-title":"Rodent Diagnostic Testing","volume":"17","author":"Jenkins","year":"2008","journal-title":"J Exot Pet Med"},{"key":"10.1016\/j.ejpb.2026.115098_b0175","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1177\/0192623319867053","article-title":"Nonproliferative and proliferative lesions of the rat and mouse hematolymphoid system","volume":"47","author":"Willard-Mack","year":"2019","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.ejpb.2026.115098_b0180","doi-asserted-by":"crossref","unstructured":"W.M. Haschek-Hock, C.G. Rousseaux, M.A. Wallig, B. Bolon, NEW: Haschek and Rousseaux's Handbook of Toxicologic Pathology, Volume 1: Principles and Practice of Toxicologic Pathology, 4th Edition - 2021, Int J Toxicol, 41 (2022) 253-254.","DOI":"10.1177\/10915818221099126"},{"key":"10.1016\/j.ejpb.2026.115098_b0185","doi-asserted-by":"crossref","unstructured":"E. McInnes, The respiratory system, in: A Practical Guide to the Histology of the Mouse, 2014, pp. 179-194.","DOI":"10.1002\/9781118789568.ch11"},{"key":"10.1016\/j.ejpb.2026.115098_b0190","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1080\/01926230701595300","article-title":"Society of Toxicologic Pathology position paper: organ weight recommendations for toxicology studies","volume":"35","author":"Sellers","year":"2007","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.ejpb.2026.115098_b0195","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1177\/096032719601500802","article-title":"Reference values for young normal Sprague-Dawley rats: weight gain, hematology and clinical chemistry","volume":"15","author":"Lillie","year":"1996","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.ejpb.2026.115098_b0200","first-page":"144","article-title":"Changes in blood parameters and the expression of coagulation-related genes in lactating Sprague-Dawley rats","volume":"51","author":"Urasoko","year":"2012","journal-title":"J. Am. Assoc. Lab. Anim. Sci."},{"key":"10.1016\/j.ejpb.2026.115098_b0205","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1258\/la.2011.011136","article-title":"Influence of tail versus cardiac sampling on blood glucose and lipid profiles in mice","volume":"46","author":"Chan","year":"2012","journal-title":"Lab Anim."},{"key":"10.1016\/j.ejpb.2026.115098_b0210","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1177\/01926233241289116","article-title":"Historical control background incidence of spontaneous nonneoplastic lesions of sprague dawley rats in 104-week carcinogenicity studies","volume":"53","author":"Bockenstedt","year":"2025","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.ejpb.2026.115098_b0215","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1538\/expanim.50.99","article-title":"Spontaneous neoplastic lesions in aged Sprague-Dawley rats","volume":"50","author":"Nakazawa","year":"2001","journal-title":"Exp. Anim."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126001190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126001190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T01:57:37Z","timestamp":1783043857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641126001190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":43,"alternative-id":["S0939641126001190"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115098","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vivo pharmacokinetic and toxicity evaluation of Andrographis paniculata extract-loaded self-microemulsifying drug delivery system","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115098","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115098"}}